NASDAQ:CRSP | Insider Transactions — Page 5 | CRISPR Therapeutics AG

CRSP Insider Transactions — Page 5

620 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 401–500; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Woiwode ThomasDirector2018-04-24Sale653.0$51.0
Woiwode ThomasDirector2018-04-24Sale589.0$50.6
Woiwode ThomasDirector2018-04-24Sale20,071.0$51.0
Bolzon Bradley J PhDDirector2018-04-24Sale1,528.0$51.0
Bolzon Bradley J PhDDirector2018-04-24Sale653.0$51.0
Bolzon Bradley J PhDDirector2018-04-24Sale589.0$50.6
Bolzon Bradley J PhDDirector2018-04-24Sale20,071.0$51.0
Versant Affiliates Fund V, L.P.TenPercentOwner2018-04-24Sale1,528.0$51.0
Versant Venture Capital V, L.P.TenPercentOwner2018-04-24Sale1,528.0$51.0
Versant Ophthalmic Affiliates I, L.P.TenPercentOwner2018-04-24Sale1,528.0$51.0
Versant Venture Capital V (Canada), LPTenPercentOwner2018-04-24Sale1,528.0$51.0
Versant Ventures V, LLCTenPercentOwner2018-04-24Sale1,528.0$51.0
Versant Affiliates Fund V, L.P.TenPercentOwner2018-04-24Sale653.0$51.0
Versant Venture Capital V, L.P.TenPercentOwner2018-04-24Sale653.0$51.0
Versant Ophthalmic Affiliates I, L.P.TenPercentOwner2018-04-24Sale653.0$51.0
Versant Venture Capital V (Canada), LPTenPercentOwner2018-04-24Sale653.0$51.0
Versant Ventures V, LLCTenPercentOwner2018-04-24Sale653.0$51.0
Versant Affiliates Fund V, L.P.TenPercentOwner2018-04-24Sale589.0$50.6
Versant Venture Capital V, L.P.TenPercentOwner2018-04-24Sale589.0$50.6
Versant Ophthalmic Affiliates I, L.P.TenPercentOwner2018-04-24Sale589.0$50.6
Versant Venture Capital V (Canada), LPTenPercentOwner2018-04-24Sale589.0$50.6
Versant Ventures V, LLCTenPercentOwner2018-04-24Sale589.0$50.6
Versant Affiliates Fund V, L.P.TenPercentOwner2018-04-24Sale20,071.0$51.0
Versant Venture Capital V, L.P.TenPercentOwner2018-04-24Sale20,071.0$51.0
Versant Ophthalmic Affiliates I, L.P.TenPercentOwner2018-04-24Sale20,071.0$51.0
Versant Venture Capital V (Canada), LPTenPercentOwner2018-04-24Sale20,071.0$51.0
Versant Ventures V, LLCTenPercentOwner2018-04-24Sale20,071.0$51.0
Versant Ventures IV, LLCTenPercentOwner2018-04-23Sale6,821.0$50.66
Versant Venture Capital IV, L.P.TenPercentOwner2018-04-23Sale6,821.0$50.66
Versant Side Fund IV, L.P.TenPercentOwner2018-04-23Sale6,821.0$50.66
Versant Affiliates Fund V, L.P.TenPercentOwner2018-04-23Sale6,821.0$50.66
Versant Venture Capital V, L.P.TenPercentOwner2018-04-23Sale6,821.0$50.66
Versant Ophthalmic Affiliates I, L.P.TenPercentOwner2018-04-23Sale6,821.0$50.66
Versant Venture Capital V (Canada), LPTenPercentOwner2018-04-23Sale6,821.0$50.66
Versant Ventures IV, LLCTenPercentOwner2018-04-23Sale2,915.0$51.0
Versant Venture Capital IV, L.P.TenPercentOwner2018-04-23Sale2,915.0$51.0
Versant Side Fund IV, L.P.TenPercentOwner2018-04-23Sale2,915.0$51.0
Versant Affiliates Fund V, L.P.TenPercentOwner2018-04-23Sale2,915.0$51.0
Versant Venture Capital V, L.P.TenPercentOwner2018-04-23Sale2,915.0$51.0
Versant Ophthalmic Affiliates I, L.P.TenPercentOwner2018-04-23Sale2,915.0$51.0
Versant Venture Capital V (Canada), LPTenPercentOwner2018-04-23Sale2,915.0$51.0
Versant Ventures IV, LLCTenPercentOwner2018-04-23Sale2,630.0$51.0
Versant Venture Capital IV, L.P.TenPercentOwner2018-04-23Sale2,630.0$51.0
Versant Side Fund IV, L.P.TenPercentOwner2018-04-23Sale2,630.0$51.0
Versant Affiliates Fund V, L.P.TenPercentOwner2018-04-23Sale2,630.0$51.0
Versant Venture Capital V, L.P.TenPercentOwner2018-04-23Sale2,630.0$51.0
Versant Ophthalmic Affiliates I, L.P.TenPercentOwner2018-04-23Sale2,630.0$51.0
Versant Venture Capital V (Canada), LPTenPercentOwner2018-04-23Sale2,630.0$51.0
Versant Ventures IV, LLCTenPercentOwner2018-04-23Sale89,628.0$50.66
Versant Venture Capital IV, L.P.TenPercentOwner2018-04-23Sale89,628.0$50.66
Versant Side Fund IV, L.P.TenPercentOwner2018-04-23Sale89,628.0$50.66
Versant Affiliates Fund V, L.P.TenPercentOwner2018-04-23Sale89,628.0$50.66
Versant Venture Capital V, L.P.TenPercentOwner2018-04-23Sale89,628.0$50.66
Versant Ophthalmic Affiliates I, L.P.TenPercentOwner2018-04-23Sale89,628.0$50.66
Versant Venture Capital V (Canada), LPTenPercentOwner2018-04-23Sale89,628.0$50.66
Woiwode ThomasDirector2018-04-23Sale6,821.0$50.66
Woiwode ThomasDirector2018-04-23Sale2,915.0$51.0
Woiwode ThomasDirector2018-04-23Sale2,630.0$51.0
Woiwode ThomasDirector2018-04-23Sale89,628.0$50.66
Bolzon Bradley J PhDDirector2018-04-23Sale6,821.0$50.66
Bolzon Bradley J PhDDirector2018-04-23Sale2,915.0$51.0
Bolzon Bradley J PhDDirector2018-04-23Sale2,630.0$51.0
Bolzon Bradley J PhDDirector2018-04-23Sale89,628.0$50.66
Dylan-Hyde TylerChief Legal Officer2018-01-16Sale19,890.0$28.1
Dylan-Hyde TylerChief Legal Officer2018-01-16Sale1,110.0$28.24
Dylan-Hyde TylerChief Legal Officer2018-01-16Sale45,000.0$28.0
BAYER AKTIENGESELLSCHAFTTenPercentOwner2018-01-05Purchase527,472.0$22.75
Bayer Global Investments B.V.TenPercentOwner2018-01-05Purchase527,472.0$22.75
EMSTER KURT VONDirector2018-01-05Purchase65,934.0$22.75
EMSTER KURT VONDirector2018-01-05Sale92,337.0$26.96
EMSTER KURT VONDirector2018-01-02Sale37,754.0$26.76
Dylan-Hyde TylerChief Legal Officer2018-01-02Sale8,000.0$25.75
Dylan-Hyde TylerChief Legal Officer2018-01-02Sale30,000.0$20.55
Dylan-Hyde TylerChief Legal Officer2017-12-29Sale15,000.0$22.68
Dylan-Hyde TylerChief Legal Officer2017-12-29Sale8,000.0$23.76
Dylan-Hyde TylerChief Legal Officer2017-12-29Sale1,070.0$21.75
Dylan-Hyde TylerChief Legal Officer2017-12-29Sale6,230.0$21.75
Dylan-Hyde TylerChief Legal Officer2017-12-28Sale700.0$21.75
Dylan-Hyde TylerChief Legal Officer2017-12-22Sale15,000.0$20.55
Bolzon Bradley J PhDDirector2017-12-22Sale26,016.0$20.3
Woiwode ThomasDirector2017-12-22Sale3,059.0$20.29
Dylan-Hyde TylerChief Legal Officer2017-12-15Sale15,000.0$18.9
CELGENE CORP /DE/TenPercentOwner2017-12-04Sale30,485.0$19.47
CELGENE CORP /DE/TenPercentOwner2017-12-01Sale87,991.0$19.1
CELGENE CORP /DE/TenPercentOwner2017-11-30Sale12,666.0$19.04
CELGENE CORP /DE/TenPercentOwner2017-11-29Sale4,263.0$19.25
CELGENE CORP /DE/TenPercentOwner2017-11-28Sale5,080.0$19.22
CELGENE CORP /DE/TenPercentOwner2017-11-27Sale27,990.0$19.75
Woiwode ThomasDirector2017-11-27Sale200.0$20.24
Bolzon Bradley J PhDDirector2017-11-27Sale200.0$20.24
CELGENE CORP /DE/TenPercentOwner2017-11-24Sale26,010.0$20.0
Woiwode ThomasDirector2017-11-24Sale1,700.0$20.21
Bolzon Bradley J PhDDirector2017-11-24Sale1,507.0$20.21
CELGENE CORP /DE/TenPercentOwner2017-11-22Sale256,000.0$19.76
CELGENE CORP /DE/TenPercentOwner2017-11-20Sale158,718.0$19.02
CELGENE CORP /DE/TenPercentOwner2017-11-17Sale51,282.0$18.44
CELGENE CORP /DE/TenPercentOwner2017-11-16Sale105,000.0$18.39
CELGENE CORP /DE/TenPercentOwner2017-11-15Sale15,000.0$17.67
CELGENE CORP /DE/TenPercentOwner2017-11-14Sale14,907.0$17.19
CELGENE CORP /DE/TenPercentOwner2017-11-13Sale65,093.0$17.76